Father hits out at madrasa for rusticating his 10-yr-old daughter over ‘bindi’

Mangaluru/Udupi, Mar 23: The coastal district of Dakshina Kannada including the city of Mangaluru today refused to return to normalcy from yesterday’s Janata Curfew, as the government imposed lockdown in the district till the month end to contain the Covid-19 caused by the deadly novel coronavirus.

The lockdown coupled with the prohibitory orders under Section 144 has forced all the commercial establishments barring few to remain closed in the district.

The police started issuing stern warning to the people through loudspeakers against venturing out of their homes unnecessarily. People are allowed to move only in case of any emergency or basic needs.

The police warning came after a few people started ignoring the lockdown and ban orders. A few private buses also were seen plying on the roads in the morning.

Under the proibitory orders, the district administration banned from venturing out of their homes except in case of emergency or extreme necessity. All public programmes including religious ceremonies, cultural programmes also are banned. All shops, commercial establishments, workshops and godowns with other unessential goods are supposed to remain closed. Bus service, both government and private, are to suspended. Mass prayers and religious ceremonies are not allowed in temples, mosques and churches. Beaches and other tourist spots are closed.

Udupi

The lockdown in 9 districts of Karnataka has forced many private buses in Udupi to stay off the roads for second day on Monday. Some buses plying between Udupi to Kundapur have resumed service a day after Janata Curfew, with very minimum occupancy.

Due to lockdown in Dakshina Kannada, all services operating from Mangaluru to Udupi, Manipal, and Kundapur have been suspended till the month end. Buses on Karkala-Udupi route have also stopped their operations.

Bengaluru, Jun 25: Secondary School Leaving Certificate (SSLC) examinations commenced in Karnataka on Thursday amid relaxation of COVID-19 lockdown restrictions.

Schools in the state ensured that social distancing norms were followed and other precautionary measures taken at the examination centres. All the students underwent thermal screening at the centres and were provided hand sanitisers and masks.

"Today, 464 students are writing the exam. In every classroom, 20 students will be writing their papers. We have also arrangements two separate classrooms for those from containment zones and those who are unwell," said Sister Sagaimir, Principal, St. Joseph's Convent Girls High School.

"We have been working for the last two weeks to put everything in place for the examination Ensuring they maintain social distancing, wear a mask and sanitise," she added.

In other schools, arrangements at the designated centres were inspected before the exams began.

Yesterday, Medical Education Minister Dr K Sudhakar held a video conference with senior officials to review the preparedness for safely conducting the SSLC examinations scheduled on June 25.

"8,48,203 students will appear for the SSLC examination starting tomorrow in 2,879 centres across the state. All the guidelines issues by state government must be followed strictly" Sudhakar said in the meeting.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.